Wikipedia -WSS

Wikipedia

author：fashion 2025-09-30 12:10:59 - browse：77614

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Lack of health data on LGBTQ+ people has serious consequences

WSS

Abridge raises $150m as clinical notes automation market heats up

The untold story of TV’s first prescription drug ad

In 'major milestone,' FDA approves first cell therapy for solid tumors

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Streamlined flu vaccines recommended by FDA advisory panel

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

hotspot

Wikipedia

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Obamacare plans could cover weight loss drugs

Jerome Adams on the need for new antivirals for Covid

He's 19 months old and has one of the world’s rarest diseases

Medical leaders decry Supreme Court decision on affirmative action

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

BioMarin wins approval for gene therapy to treat hemophilia A

$1 billion proposal to grow Boston, Massachusetts biotech

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

hotspot

State of the Union pitch: Bigger Medicare drug price negotiations

The public health thinking behind the CDC’s new Covid guidance

Florida health officials providing scant details on measles cases

FDA warns medical device makers about rise in fabricated data

Hospitals are piloting generative AI tools as regulators play catch

The untold story of TV’s first prescription drug ad

knowledge

leisure time

entertainment

hotspot